Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP My Way II
PACTR202501844121312Phase 4Not yet recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by National Institute of Mental Health. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202501844121312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501844121312.